Recurrence Patterns in Esophageal Adenocarcinoma Surgery and Chemoradiotherapy

149 propensity score-matched cases per treatment group compare recurrence rates and timing for esophageal adenocarcinoma. The dataset supports a retrospective cohort study analyzing patients treated between 2000 and 2018. Andreas Bouckaert published this research on figshare in April 2026.

Use Cases

• Compare overall recurrence rates (73.2% vs 57.0%) and time to recurrence (6.3 vs 11.5 months) between primary surgery and nCRT groups.
• Analyze locoregional recurrence timing (6.3 vs 13.6 months) and its impact on subsequent survival outcomes.
• Model overall survival after diagnosis of recurrence (6.9 vs 9.6 months) based on initial treatment strategy.
• Investigate relationships between matched variables like age, Charlson comorbidity score, and clinical tumor length with recurrence patterns.

Strengths

• 298 total patient cases (149 per treatment group) created via propensity score matching.
• Clear statistical comparisons provided for key endpoints like recurrence rates and survival times.
• Study covers an 18-year patient treatment period from 2000 to 2018.

Limitations

• Small sample size of 298 total matched cases limits statistical power for subgroup analyses.
• Retrospective, single-center study design may introduce selection bias not fully corrected by matching.
• Dataset is 66.8 KB, indicating it contains summary or processed results, not the raw patient-level data.

Provenance

Source

figshare, authored by Andreas Bouckaert.

Collection Method

Retrospective cohort study with propensity score-matched analysis of surgically treated patients.

Time Range

Patient treatment from 2000 to 2018.

Freshness

Data current through 2018, with analysis published in April 2026.